Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure

Predictors of improvement in left ventricular ejection fraction with carvedilol for congestive heart failure

Background. β-Blocker therapy has been reported to improve survival and left ventricular ejection fraction (LVEF) in the setting of congestive heart failure (CHF). The magnitude and predictors of improved LVEF are unclear. Methods. A total of 295 patients were enrolled in the study. Inclusion criter...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of nuclear cardiology 2000-01, Vol.7 (1), p.3-7
Hauptverfasser: O'Keefe, James H, Magalski, Anthony, Stevens, Tracy L, Bresnahan, Dennis R, Alaswad, Khaldoon, Krueger, Steven K, Bateman, Timothy M
Format: Artikel
Sprache:eng
Schlagworte:
Adrenergic beta-Antagonists - adverse effects
Adrenergic beta-Antagonists - therapeutic use
Aged
Carbazoles - adverse effects
Carbazoles - therapeutic use
carvedilol
congestive heart failure
Drug therapy
Female
Heart failure
Heart Failure - diagnostic imaging
Heart Failure - drug therapy
Heart Failure - physiopathology
Humans
left ventricular function
Male
Middle Aged
Propanolamines - adverse effects
Propanolamines - therapeutic use
Prospective Studies
Radionuclide Ventriculography
Stroke Volume - drug effects
β-blocker therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background. β-Blocker therapy has been reported to improve survival and left ventricular ejection fraction (LVEF) in the setting of congestive heart failure (CHF). The magnitude and predictors of improved LVEF are unclear. Methods. A total of 295 patients were enrolled in the study. Inclusion criteria were LVEF
ISSN:1071-3581
1532-6551
DOI:10.1067/mnc.2000.102678